GlassScriptPhysician profile
Eugene W Johnson
NPI 1851307276
$6,646.12
in general payments reported to CMS, 2019-2025
16 companies · $2,547 in 2025
The $2,547 reported for 2025 was more than what 95% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,772 · 2020: $321 · 2021: $245 · 2022: $170 · 2023: $1,223 · 2024: $369 · 2025: $2,547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,598 · Food and Beverage: $1,541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,598.02 |
| Food and Beverage | $1,540.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $3,244.98 | 2023-2025 | Iovera, Zilretta |
| Boston Scientific Corporation | $1,530.25 | 2019-2025 | Intracept, Artisan |
| Collegium Pharmaceutical, INC. | $673.56 | 2019-2025 | Xtampza, Belbuca |
| Abbott Laboratories | $479.36 | 2021-2025 | Eterna, Proclaim |
| Kowa Pharmaceuticals America, INC. | $280.27 | 2019-2023 | Seglentis |
| Pacira Therapeutics, INC. | $104.88 | 2019 | |
| Nevro Corp. | $79.97 | 2020-2024 | Senza |
| Allergan, INC. | $58.13 | 2019 | |
| Scilex Pharmaceuticals INC. | $57.56 | 2019-2022 | |
| Pfizer INC. | $37.61 | 2019 | |
| Daiichi Sankyo INC. | $26.71 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.28 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.99 | 2022 | |
| Zyla Life Sciences, INC. | $12.53 | 2019 | |
| Stryker Corporation | $11.89 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.